Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed

Ying Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-4214-3455; OpenAlex author ID A5100383088. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2012: 2 papers

Papers 2

  1. DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer. Co-author DOI 10.1007/s00432-012-1205-3↗
  2. Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer. Co-author DOI 10.3892/ol.2012.783↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Muxing Kang · 2 shared papers, 2012 · strength 0.07
  2. Qingqu Guo · 2 shared papers, 2012 · strength 0.07
  3. Bo Zhang · 2 shared papers, 2012 · strength 0.07
  4. Yulian Wu · 2 shared papers, 2012 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.